Japan						                            
                            
						
 Mini Review
												Significance of the Difference in the Size of Liver Tumors in the Management
of Patients with Colorectal Liver Metastases 						
Author(s): Kosuke  Ichida, Koichi  Suzuki, Taro  Fukui, Yuji  Takayama, Nao  Kakizaw, Yuta  Muto, Takaharu  Kato, Fumi  Hasegawa, Fumiaki  Watanabe, Yuji  Kaneda, Rina  Kikugaw, Masaaki  Saito, Shingo  Tsujinaka, Kazushige  Futsuhara, Yasuyuki  Miyakura, Hiroshi  Nod, Hirokazu  Kiyozaki and Toshiki  RikiyamaKosuke  Ichida, Koichi  Suzuki, Taro  Fukui, Yuji  Takayama, Nao  Kakizaw, Yuta  Muto, Takaharu  Kato, Fumi  Hasegawa, Fumiaki  Watanabe, Yuji  Kaneda, Rina  Kikugaw, Masaaki  Saito, Shingo  Tsujinaka, Kazushige  Futsuhara, Yasuyuki  Miyakura, Hiroshi  Nod, Hirokazu  Kiyozaki and Toshiki  Rikiyama             
						
												
				 Background: The combination of chemotherapy and surgery is currently accepted for the treatment of patients with technically resectable colorectal liver metastases. It is, however, hard to determine which of these modalities should be the forward treatment. In this study, we assessed the usefulness of the difference in tumor size assessed in pretherapeutic imaging in the selection of chemotherapy in these patients.
Methods: We present a retrospective review of 80 consecutive colorectal liver metastases without extrahepatic tumors. The relapse-free survival (RFS), progression-free survival (PFS) and overall survival (OS) were evaluated and compared between patients who underwent surgery (n=66) and chemotherapy (n=14) according to clinical features. In particular, we addressed pretherapeutic imaging studies including the distribution and numbe.. Read More»
				  
											  
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report